Shorter oral regimens for TB patients slash costs, A new ICMR finds
IBNS-CMEDIA: An economic evaluation published in the Indian Journal of Medical Research has demonstrated that shorter, six-month all-oral treatment regimens for multidrug-resistant and rifampicin-resistant tuberculosis (MDR/RR-TB) are cost-effective and offer …
Read More